Researching Acceptability of Biomarkers for Informing clinical Treatment (RABIT) Study

RABIT Study logo

The RABIT study is evaluating the feasibility and acceptability of using EEG and genetic testing to inform clinical decisions in primary care. We aim to identify procedures that will make these tools useful to pediatricians and other providers in the future. 

Participation

Existing MEHC patients are eligible to enroll.

Compensation

Families will receive $20 for participation in EEG and $25 for participation in genetic testing. 

Please contact us at ArnettLab@childrens.harvard.edu or call 617-919-7771 to learn more! By calling or emailing, you are not agreeing to participate. Your decision to enroll is completely voluntary and if you do decide to enroll, you may drop out of the study at any time.